We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPM icon
851
Wheaton Precious Metals
WPM
$61B
$14.9M 0.01%
396,024
+6,007
+2% +$262K
EVBG
852
DELISTED
Everbridge, Inc. Common Stock
EVBG
$14.9M 0.01%
98,445
-17,420
-15% -$2.58M
DINO icon
853
HF Sinclair
DINO
$15.2B
$14.8M 0.01%
448,204
+18,055
+4% +$549K
TRI icon
854
Thomson Reuters
TRI
$45.4B
$14.8M 0.01%
127,560
-26,148
-17% -$3.05M
MNDT
855
DELISTED
Mandiant, Inc. Common Stock
MNDT
$14.8M 0.01%
830,863
+17,420
+2% +$330K
LNG icon
856
Cheniere Energy
LNG
$54.8B
$14.8M 0.01%
151,360
-7,142
-5% -$625K
FDL icon
857
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.88B
$14.8M 0.01%
450,619
+19,720
+5% +$661K
CNP icon
858
CenterPoint Energy
CNP
$26.5B
$14.8M 0.01%
599,682
+88,781
+17% +$2.27M
AL
859
DELISTED
Air Lease Corp
AL
$14.7M 0.01%
374,841
-4,079
-1% -$166K
NBIX icon
860
Neurocrine Biosciences
NBIX
$16.5B
$14.7M 0.01%
153,332
-9,022
-6% -$852K
ADX icon
861
Adams Diversified Equity Fund
ADX
$3.28B
$14.7M 0.01%
742,453
-16,972
-2% -$344K
ESGU icon
862
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
$14.7M 0.01%
149,213
+65,038
+77% +$6.59M
PSA icon
863
Public Storage
PSA
$60.7B
$14.6M 0.01%
49,304
-369
-0.7% -$116K
DOC icon
864
Healthpeak Properties
DOC
$14.1B
$14.6M 0.01%
435,908
-1,462
-0.3% -$51.8K
RPD icon
865
Rapid7
RPD
$893M
$14.6M 0.01%
128,958
-133
-0.1% -$15.1K
LYFT icon
866
Lyft
LYFT
$6.64B
$14.6M 0.01%
271,935
+33,459
+14% +$1.77M
A icon
867
Agilent Technologies
A
$42.2B
$14.5M 0.01%
91,957
-17,245
-16% -$2.79M
RCKY icon
868
Rocky Brands
RCKY
$356M
$14.5M 0.01%
303,848
+53,100
+21% +$2.64M
FXO icon
869
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$14.4M 0.01%
325,491
+22,738
+8% +$1.01M
ESTC icon
870
Elastic
ESTC
$7.94B
$14.4M 0.01%
96,450
-24,838
-20% -$3.82M
GDDY icon
871
GoDaddy
GDDY
$11.5B
$14.4M 0.01%
206,137
+6,625
+3% +$513K
OEF icon
872
iShares S&P 100 ETF
OEF
$20.4B
$14.4M 0.01%
72,724
+4,081
+6% +$829K
MKSI icon
873
MKS Inc
MKSI
$19.9B
$14.3M 0.01%
94,978
-7,638
-7% -$1.17M
PCAR icon
874
PACCAR
PCAR
$69.7B
$14.3M 0.01%
271,737
+19,086
+8% +$1.06M
XPO icon
875
XPO
XPO
$23.8B
$14.3M 0.01%
301,368
-175,605
-37% -$8.8M

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.